Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study

Objective. Inborn errors of metabolism (IEM) are genetic conditions that are sometimes associated with intellectual  developmental disorders (IDD). The aim of this study is to contribute to the metabolic characterization of IDD of unknown etiology in Mexico. Materials and methods. Metabolic screenin...

Full description

Bibliographic Details
Main Authors: Isabel Ibarra-González, Rocío Rodríguez-Valentín, Eduardo Lazcano-Ponce, Marcela Vela-Amieva
Format: Article
Language:English
Published: Instituto Nacional de Salud Pública 2017-07-01
Series:Salud Pública de México
Subjects:
Online Access:http://www.saludpublica.mx/index.php/spm/article/view/8668
id doaj-77656ec2a3a74419b711d65277c19ff7
record_format Article
spelling doaj-77656ec2a3a74419b711d65277c19ff72020-11-24T22:37:40ZengInstituto Nacional de Salud PúblicaSalud Pública de México0036-36341606-79162017-07-01594, jul-ago42342810.21149/866816388Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico StudyIsabel Ibarra-González0Rocío Rodríguez-Valentín1Eduardo Lazcano-Ponce2Marcela Vela-Amieva3Unidad de Génetica de la Nutrición. Instituto de Investigaciones Biomédicas, UNAM-Instituto Nacional de PediatríaCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MéxicoCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MéxicoLaboratorio de Errores Innatos del Metabolismo y Tamiz, Instituto Nacional de Pediatría, México.Objective. Inborn errors of metabolism (IEM) are genetic conditions that are sometimes associated with intellectual  developmental disorders (IDD). The aim of this study is to contribute to the metabolic characterization of IDD of unknown etiology in Mexico. Materials and methods. Metabolic screening using tandem mass spectrometry and fluorometry will be performed to rule out IEM. In addition,target metabolomic analysis will be done to characterize the metabolomic profile of patients with IDD. Conclusion. Identification of new metabolomic profiles associated withIDD of unknown etiology and comorbidities will contribute to the development of novel diagnostic and therapeutic schemes for the prevention and treatment of IDD in Mexico.http://www.saludpublica.mx/index.php/spm/article/view/8668Intellectual development disordersscreeninginborn errors metabolismmetabolomics
collection DOAJ
language English
format Article
sources DOAJ
author Isabel Ibarra-González
Rocío Rodríguez-Valentín
Eduardo Lazcano-Ponce
Marcela Vela-Amieva
spellingShingle Isabel Ibarra-González
Rocío Rodríguez-Valentín
Eduardo Lazcano-Ponce
Marcela Vela-Amieva
Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study
Salud Pública de México
Intellectual development disorders
screening
inborn errors metabolism
metabolomics
author_facet Isabel Ibarra-González
Rocío Rodríguez-Valentín
Eduardo Lazcano-Ponce
Marcela Vela-Amieva
author_sort Isabel Ibarra-González
title Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study
title_short Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study
title_full Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study
title_fullStr Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study
title_full_unstemmed Metabolic screening and metabolomics analysis in the Intellectual Developmental Disorders Mexico Study
title_sort metabolic screening and metabolomics analysis in the intellectual developmental disorders mexico study
publisher Instituto Nacional de Salud Pública
series Salud Pública de México
issn 0036-3634
1606-7916
publishDate 2017-07-01
description Objective. Inborn errors of metabolism (IEM) are genetic conditions that are sometimes associated with intellectual  developmental disorders (IDD). The aim of this study is to contribute to the metabolic characterization of IDD of unknown etiology in Mexico. Materials and methods. Metabolic screening using tandem mass spectrometry and fluorometry will be performed to rule out IEM. In addition,target metabolomic analysis will be done to characterize the metabolomic profile of patients with IDD. Conclusion. Identification of new metabolomic profiles associated withIDD of unknown etiology and comorbidities will contribute to the development of novel diagnostic and therapeutic schemes for the prevention and treatment of IDD in Mexico.
topic Intellectual development disorders
screening
inborn errors metabolism
metabolomics
url http://www.saludpublica.mx/index.php/spm/article/view/8668
work_keys_str_mv AT isabelibarragonzalez metabolicscreeningandmetabolomicsanalysisintheintellectualdevelopmentaldisordersmexicostudy
AT rociorodriguezvalentin metabolicscreeningandmetabolomicsanalysisintheintellectualdevelopmentaldisordersmexicostudy
AT eduardolazcanoponce metabolicscreeningandmetabolomicsanalysisintheintellectualdevelopmentaldisordersmexicostudy
AT marcelavelaamieva metabolicscreeningandmetabolomicsanalysisintheintellectualdevelopmentaldisordersmexicostudy
_version_ 1725716159399985152